LEXINGTON, Mass.--(BUSINESS WIRE)-- Antigenics Inc. (NASDAQ: AGEN) invites investors and the general public to its 2010 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, May 12. The meeting will be held at the company's headquarters at 3 Forbes Road, Lexington, MA 02421. Registration for attendees starts at 4:30 p.m. ET.
A live webcast will be accessible from the company’s website at www.antigenics.com/webcast/ and will be archived and available for replay approximately two hours after the meeting.
Antigenics is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit www.antigenics.com.
CONTACT:
Antigenics
Media: Brad Miles, 212-477-9007 x 17
or
Investors:
Shalini Sharp, 800-962-2436
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Health Biotechnology Infectious Diseases Oncology Pharmaceutical
MEDIA:
| Logo |